CTS Corporation filed a Current Report on Form 8-K with the Securities and Exchange Commission on October 27, 2026. The filing includes an investor presentation dated October 2026, which the company intends to use for meetings with investors and analysts during the fiscal year ending December 31, 2026.
The presentation contains a cautionary statement regarding forward-looking statements. It notes that statements regarding the company's strategy, financial position, guidance, and objectives are not guarantees of future performance and are subject to various risks and uncertainties. These include supply chain disruptions, changes in the economy, integration of acquisitions, funding of government contracts, rapid technological change, and geopolitical risks.
According to the filing, CTS reported last twelve months (LTM) revenue of $571 million as of September 2026. The company reported an LTM adjusted diluted EPS of $2.75 and an LTM adjusted EBITDA margin of 24%. Approximately 60% of sales are derived from diversified end markets, which include the industrial, aerospace & defense, and medical sectors.
The company provided updated guidance for fiscal year 2026. CTS expects revenue between $580 million and $590 million. For adjusted diluted EPS, the company projects a range of $2.78 to $2.88. The guidance includes the expected impact from the Millar acquisition.
Regarding capital allocation, CTS stated that it targets returning 20% to 40% of free cash flow to shareholders through dividends and share repurchases. The company noted that it has returned approximately $319 million in cash to shareholders since 2013.
